About
Finance Manager working on financial monitoring of Jeito funds and portfolio companies; previously a financial auditor at EY specializing in healthcare.
Experience
- Quell TherapeuticsMember Board of Directorscurrent2025 — present
- JEITOOperational Investorcurrent2020 — present
- Sobi - Swedish Orphan Biovitrum AB (publ)Chairperson of the Board2024
- Swedish Orphan Biovitrum AB (Sobi)Non Executive Director2014 — 2024
- ENYO PharmaChair Board of Directors2016 — 2023Lyon Area, France
- Obseva LtdChair of the Board and NED2013 — 2023
- Frazier Healthcare VenturesSenior Advisor2009 — 2017
- Genable Technologies LimitedChairman of the Board2013 — 2016
- GlaxoSmithKlineGlaxoSmith Kline1978 — 2008
Skills & more
Biotechnology8Mergers1Business Strategy9Life Sciences5Business Development5Contract Negotiation1Global Marketing1Cross-functional Team Leadership3Mergers & Acquisitions5Venture Capital2Drug Development2Licensing1
+5 more
Start-upsBiopharmaceuticalsTechnology TransferPharmaceutical IndustryStrategyFrom Estelle's professional profile.
Colleagues at Jeito Capital
Alain Rougon
Chief Financial Officer (external provider, Prodensia) at Jeito Capital
Anastasiya Sybirna
Principal at Jeito Capital
Annette Clancy
Pharma M&A Strategy at Jeito Capital
Arnaud Rousseau
Asset Manager at Ginkgo Advisor Sarl
Benjamin Caillier
Finance Director, Jeito Capital at Jeito Capital
Boris Kere
Compliance Officer at Jeito Capital
Charlotte Formont
Senior Legal Counsel at Jeito Capital
Chloé Morlaàs
Investor Relations Director at Jeito Capital
Frequently asked questions
- Who is Estelle Ruotte?
- Finance Manager working on financial monitoring of Jeito funds and portfolio companies; previously a financial auditor at EY specializing in healthcare.
- Where does Estelle Ruotte work?
- Estelle Ruotte is Finance Manager, Fund at Jeito Capital.
Shared employers
Also worked at Quell Therapeutics6
Yogesh KamraHead of Lab Operations (UK site) at Illumina VenturesMichael TedescoAnalyst at Miami University Redhawk VenturesManish GuptaSeed-stage investor in B2B and emerging technologies companies through Merak VenturesLeigh BrodyInvestment Manager at AlbionVCFreddie DearPrincipal at Monograph Capital PartnersAnnette ClancyPharma M&A Strategy at Jeito Capital
Also worked at Sobi - Swedish Orphan Biovitrum AB (publ)3
Also worked at ENYO Pharma3
Also worked at GlaxoSmithKline137
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 131 more